# A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ABSK061 Mini-tablets in Healthy Adult Participants

> **NCT07007546** · PHASE1 · RECRUITING · sponsor: **Abbisko Therapeutics Co, Ltd** · enrollment: 42 (estimated)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** ABSK061
- **DRUG:** ABSK061
- **DRUG:** ABSK061

## Key facts

- **NCT ID:** NCT07007546
- **Lead sponsor:** Abbisko Therapeutics Co, Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-05-17
- **Primary completion:** 2025-08-30
- **Final completion:** 2025-11-30
- **Target enrollment:** 42 (ESTIMATED)
- **Last updated:** 2025-06-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07007546

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07007546, "A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ABSK061 Mini-tablets in Healthy Adult Participants". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07007546. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*